Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant topical 5-fluorouracil for ocular surface squamous neoplasia
PACTR201207000396219Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fluorouracil in ocular surface squamous neoplasia (OSSN) (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Clinical recurrence within first year. Started Aug 2012; status: completed.
02
Drugs
fluorouracil
03
Conditions
ocular surface squamous neoplasia (OSSN)
Beyond the preview
Go deeper on PACTR201207000396219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201207000396219.